![Gregory D. Plowman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory D. Plowman
Director/Board Member at
New York Biotechnology Association, Inc.
Profile
Gregory D.
Plowman is currently a Director at New York Biotechnology Association, Inc., AurKa Pharma, Inc., and Acanthas Pharma, Inc. He was previously a Senior Vice President at ImClone LLC, Vice President-Oncology Research at Eli Lilly & Co., and Chief Technology Officer at Exelixis, Inc. Plowman holds a doctorate from the University of Washington and an undergraduate degree from Whitman College.
Gregory D. Plowman active positions
| Companies | Position | Start |
|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Director/Board Member | - |
Acanthas Pharma, Inc.
 Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 18/03/2019 |
Former positions of Gregory D. Plowman
| Companies | Position | End |
|---|---|---|
AurKa Pharma, Inc.
 AurKa Pharma, Inc. BiotechnologyHealth Technology Develops medication for cancer treatment | Director/Board Member | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Gregory D. Plowman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitman College
 Whitman College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
AurKa Pharma, Inc.
AurKa Pharma, Inc. BiotechnologyHealth Technology Develops medication for cancer treatment | Health Technology |
Acanthas Pharma, Inc.
Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Gregory D. Plowman
Choose MarketScreener 
